NCT00294567View on ClinicalTrials.gov

Azelnidipine Anti-Coronary Atherosclerotic Trial in Hypertensive Patients by Serial Volumetric IVUS Analysis(ALPS-J)

PHASE4CompletedINTERVENTIONAL
Enrollment

199

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

May 31, 2009

Study Completion Date

January 31, 2011

Conditions
HypertensionCoronary Atherosclerosis
Interventions
DRUG

Calcium channel blockers (amlodipine, azelnidipine)

Drug: amlodipine Drug: azelnidipine

Trial Locations (1)

Unknown

Department of Cardiology, Juntendo University School of Medicine, Tokyo

All Listed Sponsors
collaborator

Japan Heart Foundation

OTHER

lead

Juntendo University

OTHER

NCT00294567 - Azelnidipine Anti-Coronary Atherosclerotic Trial in Hypertensive Patients by Serial Volumetric IVUS Analysis(ALPS-J) | Biotech Hunter | Biotech Hunter